Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Guardant Health, Inc. - Common Stock (NQ:GH)

125.61 -7.45 (-5.60%)

Streaming Delayed Price Updated: 4:00 PM EDT, Jun 5, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	3,345,532
Open	133.00
Bid (Size)	125.00 (100)
Ask (Size)	129.17 (7,000)
Prev. Close	133.06
Today's Range	124.91 - 133.34
52wk Range	40.35 - 134.28
Shares Outstanding	101,298,669
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

1 Cash-Burning Stock with Promising Prospects and 2 Facing Headwinds

June 05, 2026

Companies that burn cash at a rapid pace can run into serious trouble if they fail to secure funding. Without a clear path to profitability, these businesses...

Via StockStory

June 04, 2026

When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fea...

Via StockStory

Performance

YTD	+23.5%	+23.5%
1 Month	+36.2%	+36.2%
3 Month	+37.7%	+37.7%
6 Month	+23.1%	+23.1%
1 Year	+159.5%	+159.5%

More News

3 Unprofitable Stocks Walking a Fine Line

June 01, 2026

Via StockStory

3 Reasons GH is Risky and 1 Stock to Buy Instead

June 01, 2026

Via StockStory

Guardant Health (NASDAQ:GH) Smashes Q1 Estimates, Raises Full-Year Guidance on Soaring Screening Revenue ↗

May 07, 2026

Via Chartmill

This $5.5 Million Exit Raises Questions After Wave Life Sciences' Rough First Quarter ↗

May 31, 2026

Via The Motley Fool

Testing & Diagnostics Services Stocks Q1 Earnings: Guardant Health (NASDAQ:GH) Firing on All Cylinders

May 28, 2026

Via StockStory

Guardant Health and Collaborators to Present 38 Abstracts Highlighting Breadth and Expanded Clinical Utility of Guardant Liquid Biopsy Tests Powered by InfinityAI at 2026 ASCO Annual Meeting

May 28, 2026

From Guardant Health, Inc.

Via Business Wire

American Cancer Society Recommends Guardant Health’s Shield Blood Test in Updated Colorectal Cancer Screening Guidelines

May 27, 2026

From Guardant Health, Inc.

Via Business Wire

3 Growth Stocks We’re Skeptical Of

May 26, 2026

Via StockStory

This Biotech Is Up 60%. A Top Healthcare Fund Just Bought Another $11 Million ↗

May 24, 2026

Via The Motley Fool

This Biotech Stock Is Up 355%. One Fund Added a $169 Million Position Last Quarter ↗

May 24, 2026

Via The Motley Fool

3 of Wall Street’s Favorite Stocks Walking a Fine Line

May 21, 2026

Via StockStory

FDA Approves New Guardant360 Liquid CDx, the Largest FDA-Approved Liquid Biopsy Panel with a 100x Expanded Footprint

May 20, 2026

From Guardant Health, Inc.

Via Business Wire

Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

May 18, 2026

From Guardant Health, Inc.

Via Business Wire

Why Guardant Health (GH) Stock Is Down Today

May 15, 2026

Via StockStory

The Top 5 Analyst Questions From Guardant Health’s Q1 Earnings Call

May 14, 2026

Via StockStory

Guardant Health (GH) Q1 2026 Earnings Transcript ↗

May 08, 2026

Via The Motley Fool

GH Q1 Deep Dive: Shield Volume Acceleration and Oncology Portfolio Expansion Fuel Growth

May 08, 2026

Via StockStory

Guardant Health (NASDAQ:GH) Delivers Impressive Q1 CY2026, Stock Soars

May 07, 2026

Via StockStory

Guardant Health Reports First Quarter 2026 Financial Results and Increases 2026 Revenue Guidance

May 07, 2026

From Guardant Health, Inc.

Via Business Wire

Guardant Health Earnings: What To Look For From GH

May 05, 2026

Via StockStory

Guardant Health Receives FDA Approval for Guardant360® CDx as a Companion Diagnostic for Arvinas and Pfizer’s VEPPANU (vepdegestrant) for Patients with ER+/HER2- Advanced Breast Cancer with ESR1 Mutations

May 04, 2026

From Guardant Health, Inc.

Via Business Wire

Guardant Health Announces Multi-Year Strategic Collaboration with Nuvalent to Develop Companion Diagnostics and Support Potential Commercialization of Targeted Cancer Therapies Using the Guardant Infinity™ Platform

April 30, 2026

From Guardant Health, Inc.

Via Business Wire

Guardant Health to Participate in Upcoming Investor Conferences

April 29, 2026

From Guardant Health, Inc.

Via Business Wire

Frequently Asked Questions

Is Guardant Health, Inc. - Common Stock publicly traded?

Yes, Guardant Health, Inc. - Common Stock is publicly traded.

What exchange does Guardant Health, Inc. - Common Stock trade on?

Guardant Health, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Guardant Health, Inc. - Common Stock?

The ticker symbol for Guardant Health, Inc. - Common Stock is GH on the Nasdaq Stock Market

What is the current price of Guardant Health, Inc. - Common Stock?

The current price of Guardant Health, Inc. - Common Stock is 125.61

When was Guardant Health, Inc. - Common Stock last traded?

The last trade of Guardant Health, Inc. - Common Stock was at 06/05/26 04:00 PM ET

What is the market capitalization of Guardant Health, Inc. - Common Stock?

The market capitalization of Guardant Health, Inc. - Common Stock is 12.72B

How many shares of Guardant Health, Inc. - Common Stock are outstanding?

Guardant Health, Inc. - Common Stock has 13B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.